MD Anderson Cancer Center, GI Medical Oncology Dept

Houston, Texas 77030

1 studies enrolling now · 1 studies all time

What they study most

Biliary Tract Cancer (BTC), Gastric or Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma

Studies at this site

• Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) — Recruiting now